Company Announces Participation at KeyBanc
Capital Markets Teleconference
and Congress of Neurological Surgeons Annual Meeting
BOSTON, Oct 6, 2005 --(HSMN NewsFeed)--NeuroSystems, LLC today provided an
update on its Multimodality Neurosurgical Critical Care Monitoring System.
The product of years of development by the company's team
of NeuroMonitoring industry veterans and professionals from the fields of neurology,
mathematics and sensor technology, NeuroSystems 1 (tm) displays, in real-time,
critical neurophysiologic functions including autoregulation, vasoreactivity and
oxygen metabolic index.
The monitoring system, which received 510(k) clearance from
the U.S. Food and Drug Administration earlier this year, was designed to accelerate
the incorporation of new modalities into the neurotrauma and cerebrovascular disease
(CVD) monitoring regime. Clinical feedback on NeuroSystems 1 is affirming this
goal.
One of the leading proponents of multimodality-focused NeuroMonitoring,
Walter Johnson, MD, Vice Chairman of Neurosurgery and Associate Professor of Surgery
at Loma Linda University Medical Center, said, "The NeuroSystems monitor has been
an important addition to our neurosurgical ICU. If we are to make the most of
multimodality monitoring, we need to monitor clinically useful data relationships
in each patient, continuously and in real-time, not just record the values of
individual parameters. This multimodality approach will become the standard of
care in neurotrauma and cerebrovascular disease critical care."
NeuroSystems is also pleased to announce that it is collaborating
in the development of a new sensor technology for the neurosurgical ICU. The ultimate
goal of the company being to provide disposable multimodality sensors with wireless
connection to the NeuroSystems monitor.
NeuroSystems will discuss its technology and trends in NeuroMonitoring
at the KeyBanc Capital Markets NeuroMonitoring teleconference from Boston on October
10, and will participate as an exhibitor at the Congress of Neurological Surgeons
annual meeting, October 10-12, 2005.
About NeuroSystems
NeuroSystems' mission is to develop and market innovative
monitoring systems that enable improved management of traumatic brain injury and
cerebrovascular disease. For additional information, please visit www.neurosystemsllc.com
.
# # #
